IgE bullous disease

Clinical and Experimental Dermatology

Volumn 22, Issue 2, 1997, Pages 82-86

  Talanin, N Y ^a   Shelley, W B ^a   Shelley, E D ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFADROXIL; IMMUNOGLOBULIN E;

ABOVE KNEE AMPUTATION; AGED; ANTIBIOTIC THERAPY; ANTIBODY DETECTION; ARTICLE; BULLOUS SKIN DISEASE; CASE REPORT; FEMALE; GANGRENE; HUMAN; IMMUNOFLUORESCENCE TEST; MALE; PRIORITY JOURNAL;

AGED; AMPUTATION; COMPLEMENT C3; ELECTRIC POWER SUPPLIES; FEMALE; GANGRENE; HUMANS; HYPERSENSITIVITY, DELAYED; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; LEG; MALE; PEMPHIGOID, BULLOUS; SKIN;

EID: 0030824209     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2230.1997.tb02625.x     Document Type: Article

References (20)

1. Korman NJ. Bullous pemphigoid. Dermatologic Clinics 1993; 11: 483-98.
2. Harlow E, Lane D. Antibodies: A Laboratory Manual. New York: Cold Spring Harbor Laboratory Press, 1988: 361-419.
3. Stanley JR, Alvarez OM, Bere EW et al. Detection of basement membrane zone antigens during epidermal wound healing in pigs. J Invest Dermatol 1981; 77: 240-3.
4. Nieboer C, van Leeuwen JE. IgE in the serum and on mast cells in bullous pemphigoid. Arch Dermatol 1980; 116: 555-6.
5. Parodi A, Rebora A. Serum IgE antibodies bind to the epidermal side of the basement membrane zone splits in bullous pemphigoid. Br J Dermatol 1992; 126: 526-7.
6. Soh H, Hosokawa H, Asada Y. IgE and its related phenomena in bullous pemphigoid. Br J Dermatol 1993; 128: 371-7.
7. Kubba R, Champion RH. Nickel sensitivity resembling bullous pemphigoid. Br J Dermatol 1975; 93 Suppl. 11: 41-3.
8. Verbov J. Pacemaker contact sensitivity. Contact Dermatitis 1985; 12: 173.
9. Boerner CF. Allergic response to a porcine collagen corneal shield. Arch Ophthalmol 1988; 106: 171.
10. Shelley WB, Marples RR. Bullous skin test response to bacterial antigens. Ann Allergy 1969; 27: 337-42.
11. Epstein S. Bullous reactions to bacterial antigens in dermatitis herpetiformis. J Invest Dermatol 1959; 33: 31-3.
12. Thomas I, Khorenian S, Arbesfeld DM. Treatment of generalized bullous pemphigoid with oral tetracycline. J Am Acad Dermatol 1993; 28: 74-7.
13. Fox BJ, Odom RB, Findlay RF. Erythromycin therapy in bullous pemphigoid: possible anti-inflammatory effects. J Am Acad Dermatol 1982; 7: 504-10.
14. Dobbins JJ, Seligson D, Raff MJ. Bacterial colonization of orthopaedic fixation devices in the absence of clinical infection. J Infect Dis 1988; 158: 203-5.
15. Kaebnick HW, Bandyk DF, Bergamini TW, Towne JB. The microbiology of explanted vascular prostheses. Surgery 1987; 102: 756-62.
16. Jordon RE, Kawana S, Fritz KA. Immunopathologic mechanisms in pemphigus and bullous pemphigoid. J Invest Dermatol 1985; 85: 72s-8s.
17. Gleich GJ, Frigas E, Loegering DA, et al. Cytotoxic properties of the eosinophil major basic protein. J Immunol 1979; 123: 2925-7.
18. Young JDE, Peterson CGB, Venge P, Cohn ZA. Mechanism of membrane damage mediated by human eosinophil cationic protein. Nature 1986; 321: 613-16.
19. Wintroub BU, Dvorak AM, Mihm MC, Gleich GJ. Bullous pemphigoid: cytotoxic degranulation and release of eosinophilic major basic protein. J Invest Dermatol 1981; 76: 310-11.
20. Mudde GC, Bheekha R, Bruijnzeel-Koomen CAMF. IgE-mediated antigen presentation. Allergy 1995; 50: 193-9.